Morgan Stanley upgrades South Korea's stock market to overweight with a 9,000 target

iconKuCoinFlash
Share
This is the logo of the coin.
META
----
AI summary iconSummary
On August 3, 2026, Morgan Stanley upgraded the South Korean stock market to 'Overweight' with a 9,000-point target. This follows aggressive deleveraging, with the KOSPI at historical lows. Hedge funds have reduced exposure by 75%, and leveraged ETFs by 70%. On-chain data indicates an improved market structure. Altcoins to watch may benefit from broader risk-on sentiment. Key catalysts include capital management trends, HBM4 pricing, and the iPhone 18 cycle.

ME News reports that on August 3 (UTC+8), Morgan Stanley upgraded its rating on the Korean stock market to "Overweight" with a target price of 9,000 points, implying a 36% upside from current levels. Morgan Stanley believes that the previous sharp deleveraging cycle is nearing its end, with the KOSPI valuation having fallen to historic lows, creating a more attractive entry point for investors. Data shows that hedge funds have completed approximately 75% of their deleveraging, while leveraged ETF assets have declined by 70% from their peak, significantly improving the market’s ownership structure. Capital flows, HBM4 pricing, and the iPhone 18 release cycle are the three key catalysts expected to drive the next phase of gains in Korean equities. (Source: BlockBeats)

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.